Quantcast

Latest ovarian cancer Stories

2014-05-16 12:27:57

RnRMarketResearch.com adds "Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies" to its store. DALLAS, May 16, 2014 /PRNewswire-iReach/ -- "Ovarian Cancer Therapeutics in Major Developed Markets to 2020 Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies". The current Ovarian cancer therapeutics market is dominated by the use of generics - predominately...

2014-05-15 08:31:37

ROCKVILLE, Md., May 15, 2014 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, today reported financial results for the three months ended March 31, 2014. http://photos.prnewswire.com/prnvar/20010620/ENMDLOGO The Company reported a net loss for the first quarter of 2014 of ($1.5 million), or ($0.05) per share, compared with a net loss of ($1.1 million), or ($0.05) per share,...

2014-05-14 23:01:58

Broadway Star and National Ovarian Cancer Coalition’s National Spokesperson, and Survivor, Valisia LeKae, Will Attend the Northern VA Chapter’s 12th Annual Run/Walk to Break the Silence on Ovarian Cancer® 5K and TEAL Mile, on Sunday, May 18, 2014, at Fairfax Corner Dallas, TX (PRWEB) May 14, 2014 Grammy and Tony Award Nominee, Valisia LeKae, was starring in the Broadway role of a lifetime, playing Diana Ross in “Motown the Musical.” Then Valisia was diagnosed with ovarian...

2014-05-09 13:19:57

Georgia Institute of Technology When ovarian cancer spreads from the ovaries it almost always does so to a layer of fatty tissue that lines the gut. A new study has found that ovarian cancer cells are more aggressive on these soft tissues due to the mechanical properties of this environment. The finding is contrary to what is seen with other malignant cancer cells that seem to prefer stiffer tissues. "What we found is that there are some cancer cells that respond to softness as opposed...

2014-05-09 13:00:57

Virginia Commonwealth University Mutations in the BRCA1 and BRCA2 genes account for nearly 25 percent of hereditary breast cancers and most hereditary ovarian cancers, yet a study by cancer prevention and control researchers at Virginia Commonwealth University Massey Cancer Center suggests an alarmingly small amount of women who qualify for BRCA genetic counseling actually receive the services. Additionally, they found that a significant proportion of women with a family history of breast...

2014-05-08 16:28:16

AUSTIN, Texas, May 8, 2014 /PRNewswire/ -- A new research collaboration anchored by Moffitt Cancer Center in Tampa, Fla., was announced today in conjunction with World Ovarian Cancer Day. The purpose of the study is to produce clinical and economic data to support a new value-based practice model that may improve survival, quality of life and cost-effectiveness of care for patients with ovarian cancer. The study will be led by Johnathan M. Lancaster, M.D., Ph.D., a gynecologic...

2014-05-07 23:00:23

ResearchMoz.us include new market research report "Ovarian Cancer Therapeutics to 2020" to its huge collection of research reports. Get Detail Report With TOC at http://www.researchmoz.us/ovarian-cancer-therapeutics-to-2020-late-stage-pipeline-focuses-on-improved-progression-free-survival-and-targeted-therapies-report.html. Albany, New York (PRWEB) May 08, 2014 Researchmoz presents this most up-to-date research on "Ovarian Cancer Therapeutics to 2020 - Late-Stage Pipeline...

2014-05-06 16:29:13

LONDON, May 6, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapieshttp://www.reportbuyer.com/pharma_healthcare/diseases/solid_tumors_market_asia_pacific_2019_new_drug_approvals_anticipated_product_launches_trigger_shift_treatment_paradigm_targeted_therapies.htmlSolid Tumors Market in Asia Pacific to...

2014-05-05 20:26:04

LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arriveshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/world_market_cancer_diagnostics_5th_edition_precision_personalized_testing_arrives.htmlCancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis,...

2014-05-05 10:12:05

Inhibiting enzymes that cause changes in gene expression could decrease chemotherapy resistance in ovarian cancer patients, researchers at Georgia State University and the University of Georgia say. Dr. Susanna Greer, associate professor of biology, and research partners at the University of Georgia have identified two enzymes that suppress proteins that are important for regulating cell survival and chemoresistance in ovarian cancer. Their findings are published in the journal, PLOS ONE....


Latest ovarian cancer Reference Libraries

Ovaries
2013-03-05 14:55:04

The ovaries are the two reproductive female organs where the eggs are produced. These are parallel to the testes in men. Formation and Orientation Each ovary is the size of an almond and is located on one side of the pelvis before the ureter and internal iliac artery but after the external iliac artery. They are attached to either side of the uterus. They are connected and release eggs to fallopian tubes, though not attached, monthly during the menstrual cycle. They also produce...

More Articles (1 articles) »
Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.